Qualigen Therapeutics, Inc. (QLGN) Financials

QLGN Assets vs Liabilities

DateAssetsLiabilities
2023-09-30 4.3 million 6.0 million
2023-06-30 13.1 million 9.8 million
2023-03-31 19.1 million 10.3 million
2022-12-31 19.1 million 10.3 million

QLGN Free Cash Flow and Stock based compensation

Graph available only for supporters. Become a supporter to see it.
DateFree Cash FlowStock based compensation
2023-09-30 1.2 million 122696
2023-06-30 -3.0 million 653919
2023-03-31 -2.5 million 1.4 million
2022-12-31 -2.5 million 1.4 million

QLGN Net Income

No data available :(

QLGN Cash and Debt

Graph available only for supporters. Become a supporter to see it.
DateCashDebtCapital Lease
2023-09-30 2.1 million - -
2023-06-30 1.3 million - 1.4 million
2023-03-31 7.0 million - 1.5 million
2022-12-31 - - 1.7 million

QLGN Shares Outstanding

Graph available only for supporters. Become a supporter to see it.
DateShares Outstanding
2023-09-30 5.1 million
2023-06-30 5.1 million
2023-03-31 3.8 million
2022-12-31 4.2 million

QLGN Expenses

Graph available only for supporters. Become a supporter to see it.
DateCapexR&DG&AS&M
2023-09-30 246418 1.4 million 1.3 million -
2023-06-30 48409 1.3 million 2.7 million 169223
2023-03-31 244374 1.8 million 2.7 million 267129
2022-12-31 244374 1.8 million 2.9 million -

QLGN Cost of Revenue

Graph available only for supporters. Become a supporter to see it.
DateRevenueCost of Revenue
2023-09-30 - -
2023-06-30 1.6 million 1.0 million
2023-03-31 1.4 million 1.1 million
2022-12-31 1.4 million 1.1 million

QLGN

Price: $0.30

52 week price:
0.29
1.26

Earnings Per Share: -4.07 USD

P/E Ratio: -0.13

Exchange: NCM

Sector: Healthcare

Industry: Biotechnology

Volume: 69100

Market Capitalization: 1.9 million

Links: